Top

Published in:

Open Access 01-12-2021 | Sarcopenia | Research

Factors associated with sarcopenia screened by finger-circle test among middle-aged and older adults: a population-based multisite cross-sectional survey in Japan

Authors: Daiki Watanabe, Tsukasa Yoshida, Takashi Nakagata, Naomi Sawada, Yosuke Yamada, Kayo Kurotani, Kenji Tanaka, Megumi Okabayashi, Hidekazu Shimada, Hidemi Takimoto, Nobuo Nishi, Keiichi Abe, Motohiko Miyachi

Published in: BMC Public Health | Issue 1/2021

Abstract

Background

Previous epidemiological studies have demonstrated the prevalence and relationship of various factors associated with sarcopenia in older adults; however, few have examined the status of sarcopenia in middle-aged adults. In this study, we aimed to, 1) evaluate the validity of the finger-circle test, which is potentially a useful screening tool for sarcopenia, and 2) determine the prevalence and factors associated with sarcopenia in middle-aged and older adults.

Methods

We conducted face-to-face surveys of 525 adults, who were aged 40–91 years and resided in Settsu City, Osaka Prefecture, Japan to evaluate the validity of finger-circle test. The finger-circle test evaluated calf circumference by referring to an illustration printed on the survey form. The area under the receiver operating characteristic curves (AUROC) was plotted to evaluate the validity of the finger-circle test for screening sarcopenia and compared to that evaluated by skeletal muscle mass index (SMI) measured using bioimpedance. We also conducted multisite population-based cross-sectional anonymous mail surveys of 9337 adults, who were aged 40–97 years and resided in Settsu and Hannan Cities, Osaka Prefecture, Japan. Participants were selected through stratified random sampling by sex and age in the elementary school zones of their respective cities. We performed multiple logistic regression analysis to explore associations between characteristics and prevalence of sarcopenia.

Results

Sarcopenia, defined by SMI, was moderately predicted by a finger-circle test response showing that the subject’s calf was smaller than their finger-circle (AUROC: 0.729, < 65 years; 0.653, ≥65 years); such subjects were considered to have sarcopenia. In mail surveys, prevalence of sarcopenia screened by finger-circle test was higher in older subjects (approximately 16%) than in middle-aged subjects (approximately 8–9%). In a multiple regression model, the factors associated with sarcopenia were age, body mass index, smoking status, self-reported health, and number of meals in all the participants.

Conclusions

Sarcopenia, screened by the finger-circle test, was present not only among older adults but also among middle-aged adults. These results may provide useful indications for developing public health programs, not only for the prevention, but especially for the management of sarcopenia.

Trial registration

UMIN000036880, registered prospectively May 29, 2019, https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000042027

Available only for authorised users

Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyere O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16–31. https://doi.org/10.1093/ageing/afy169.

Chen LK, Woo J, Assantachai P, Auyeung TW, Chou MY, Iijima K, et al. Asian working Group for Sarcopenia: 2019 consensus update on sarcopenia diagnosis and treatment. J Am Med Dir Assoc. 2020;21(3):300–7 e302. https://doi.org/10.1016/j.jamda.2019.12.012.

Fielding RA, Vellas B, Evans WJ, Bhasin S, Morley JE, Newman AB, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc. 2011;12(4):249–56. https://doi.org/10.1016/j.jamda.2011.01.003.

Morley JE, Abbatecola AM, Argiles JM, Baracos V, Bauer J, Bhasin S, et al. Sarcopenia with limited mobility: an international consensus. J Am Med Dir Assoc. 2011;12(6):403–9. https://doi.org/10.1016/j.jamda.2011.04.014.

Brown JC, Harhay MO, Harhay MN. Sarcopenia and mortality among a population-based sample of community-dwelling older adults. J Cachexia Sarcopenia Muscle. 2016;7(3):290–8. https://doi.org/10.1002/jcsm.12073.CrossRefPubMed

Nakamura K, Yoshida D, Honda T, Hata J, Shibata M, Hirakawa Y, et al. Prevalence and mortality of sarcopenia in a community-dwelling older Japanese population: the Hisayama study. J Epidemiol. 2020. https://doi.org/10.2188/jea.JE20190289.

Bianchi L, Ferrucci L, Cherubini A, Maggio M, Bandinelli S, Savino E, et al. The predictive value of the EWGSOP definition of sarcopenia: results from the InCHIANTI study. J Gerontol A Biol Sci Med Sci. 2016;71(2):259–64. https://doi.org/10.1093/gerona/glv129.

Anker SD, Morley JE, von Haehling S. Welcome to the ICD-10 code for sarcopenia. J Cachexia Sarcopenia Muscle. 2016;7(5):512–4. https://doi.org/10.1002/jcsm.12147.CrossRefPubMedPubMedCentral

Caan BJ, Cespedes Feliciano EM, Prado CM, Alexeeff S, Kroenke CH, Bradshaw P, et al. Association of Muscle and Adiposity Measured by computed tomography with survival in patients with nonmetastatic breast Cancer. JAMA Oncol. 2018;4(6):798–804. https://doi.org/10.1001/jamaoncol.2018.0137.

10.

Cruz-Jentoft AJ, Sayer AA. Sarcopenia. Lancet. 2019;393(10191):2636–46. https://doi.org/10.1016/S0140-6736(19)31138-9.CrossRefPubMed

11.

Kawakami R, Murakami H, Sanada K, Tanaka N, Sawada SS, Tabata I, et al. Calf circumference as a surrogate marker of muscle mass for diagnosing sarcopenia in Japanese men and women. Geriatr Gerontol Int. 2015;15(8):969–76. https://doi.org/10.1111/ggi.12377.

12.

Kawakami R, Miyachi M, Sawada SS, Torii S, Midorikawa T, Tanisawa K, et al. Cut-offs for calf circumference as a screening tool for low muscle mass: WASEDA'S health study. Geriatr Gerontol Int. 2020;20(10):943–50. https://doi.org/10.1111/ggi.14025.

13.

Barbosa-Silva TG, Bielemann RM, Gonzalez MC, Menezes AM. Prevalence of sarcopenia among community-dwelling elderly of a medium-sized south American city: results of the COMO VAI? Study. J Cachexia Sarcopenia Muscle. 2016;7(2):136–43.CrossRef

14.

Tanaka T, Takahashi K, Akishita M, Tsuji T, Iijima K. "Yubi-wakka" (finger-ring) test: a practical self-screening method for sarcopenia, and a predictor of disability and mortality among Japanese community-dwelling older adults. Geriatr Gerontol Int. 2018;18(2):224–32. https://doi.org/10.1111/ggi.13163.CrossRefPubMed

15.

Hiraoka A, Izumoto H, Ueki H, Yoshino T, Aibiki T, Okudaira T, et al. Easy surveillance of muscle volume decline in chronic liver disease patients using finger-circle (yubi-wakka) test. J Cachexia Sarcopenia Muscle. 2019;10(2):347–54. https://doi.org/10.1002/jcsm.12392.

16.

Yu R, Wong M, Leung J, Lee J, Auyeung TW, Woo J. Incidence, reversibility, risk factors and the protective effect of high body mass index against sarcopenia in community-dwelling older Chinese adults. Geriatr Gerontol Int. 2014;14(Suppl 1):15–28. https://doi.org/10.1111/ggi.12220.CrossRefPubMed

17.

Murakami M, Hirano H, Watanabe Y, Sakai K, Kim H, Katakura A. Relationship between chewing ability and sarcopenia in Japanese community-dwelling older adults. Geriatr Gerontol Int. 2015;15(8):1007–12. https://doi.org/10.1111/ggi.12399.CrossRefPubMed

18.

Kim H, Suzuki T, Kim M, Kojima N, Yoshida Y, Hirano H, et al. Incidence and predictors of sarcopenia onset in community-dwelling elderly Japanese women: 4-year follow-up study. J Am Med Dir Assoc. 2015;16(1):85 e81–8.

19.

Petermann-Rocha F, Chen M, Gray SR, Ho FK, Pell JP, Celis-Morales C. Factors associated with sarcopenia: a cross-sectional analysis using UK biobank. Maturitas. 2020;133:60–7. https://doi.org/10.1016/j.maturitas.2020.01.004.CrossRefPubMed

20.

Murphy RA, Ip EH, Zhang Q, Boudreau RM, Cawthon PM, Newman AB, et al. Transition to sarcopenia and determinants of transitions in older adults: a population-based study. J Gerontol A Biol Sci Med Sci. 2014;69(6):751–8. https://doi.org/10.1093/gerona/glt131.

21.

Pang BWJ, Wee SL, Lau LK, Jabbar KA, Seah WT, Ng DHM, et al. Prevalence and Associated Factors of Sarcopenia in Singaporean Adults-The Yishun Study. J Am Med Dir Assoc. 2021;22(4):885.e1–885.e10. https://doi.org/10.1016/j.jamda.2020.05.029.

22.

Steffl M, Bohannon RW, Petr M, Kohlikova E, Holmerova I. Relation between cigarette smoking and sarcopenia: meta-analysis. Physiol Res. 2015;64(3):419–26. https://doi.org/10.33549/physiolres.932802.CrossRefPubMed

23.

Dodds RM, Granic A, Robinson SM, Sayer AA. Sarcopenia, long-term conditions, and multimorbidity: findings from UK biobank participants. J Cachexia Sarcopenia Muscle. 2020;11(1):62–8. https://doi.org/10.1002/jcsm.12503.CrossRefPubMed

24.

Gill TM, Baker DI, Gottschalk M, Peduzzi PN, Allore H, Byers A. A program to prevent functional decline in physically frail, elderly persons who live at home. N Engl J Med. 2002;347(14):1068–74. https://doi.org/10.1056/NEJMoa020423.CrossRefPubMed

25.

Dodds RM, Syddall HE, Cooper R, Benzeval M, Deary IJ, Dennison EM, et al. Grip strength across the life course: normative data from twelve British studies. PLoS One. 2014;9(12):e113637. https://doi.org/10.1371/journal.pone.0113637.

26.

e-Stat. Population (total and Japanese population), by age (single years) and sex, percentage by age, average age and median age - Japan*, all shi, all gun, prefectures*, all shi of prefectures, all gun of prefectures, shi*, ku*, machi*, mura* and municipalities in 2016 [In Japanese]. Available: https://www.e-stat.go.jp/stat-search/file-download?statInfId=000031473210&fileKind=1. Accessed 6th Nov 2020.

27.

Yamada Y, Nishizawa M, Uchiyama T, Kasahara Y, Shindo M, Miyachi M, et al. Developing and Validating an Age-Independent Equation Using Multi-Frequency Bioelectrical Impedance Analysis for Estimation of Appendicular Skeletal Muscle Mass and Establishing a Cutoff for Sarcopenia. Int J Environ Res Public Health. 2017;14(7):809. https://doi.org/10.3390/ijerph14070809.

28.

Rodriguez-Rejon AI, Artacho R, Puerta A, Zuniga A, Ruiz-Lopez MD. Diagnosis of sarcopenia in Long-term care homes for the elderly: the sensitivity and specificity of two simplified algorithms with respect to the EWGSOP consensus. J Nutr Health Aging. 2018;22(7):796–801. https://doi.org/10.1007/s12603-018-1004-x.CrossRefPubMed

29.

Chang HK, Lee JY, Gil CR, Kim MK. Prevalence of sarcopenia in community-dwelling older adults according to simplified algorithms for sarcopenia consensus based on Asian working Group for Sarcopenia. Clin Interv Aging. 2020;15:2291–9. https://doi.org/10.2147/CIA.S281131.CrossRefPubMedPubMedCentral

30.

Yoshida T, Watanabe D, Nakagata T, Yamada Y, Kurotani K, Sawada N, Tanaka K, Okabayashi M, Shimada H et al. Prevalence of frailty and its related factors in community-dwelling middle-aged and elderly adults in Settsu and Hannan cities in Osaka prefecture. Nihon-Koshu-Eisei-Zasshi (in press) [Japanese]. Accessed 10 Feb 2020.

31.

van Buuren S. Karin Groothuis-Oudshoorn: mice: multivariate imputation by chained equations in R. J Stat Softw. 2011;45(3):1–67.CrossRef

32.

Leong A, Dasgupta K, Chiasson JL, Rahme E. Estimating the population prevalence of diagnosed and undiagnosed diabetes. Diabetes Care. 2013;36(10):3002–8. https://doi.org/10.2337/dc12-2543.CrossRefPubMedPubMedCentral

33.

Kim H, Hirano H, Edahiro A, Ohara Y, Watanabe Y, Kojima N, et al. Sarcopenia: prevalence and associated factors based on different suggested definitions in community-dwelling older adults. Geriatr Gerontol Int. 2016;16(Suppl 1):110–22. https://doi.org/10.1111/ggi.12723.

34.

Sterne JA, White IR, Carlin JB, Spratt M, Royston P, Kenward MG, et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ. 2009;338:b2393. https://doi.org/10.1136/bmj.b2393.

35.

Grimes DA, Schulz KF. Uses and abuses of screening tests. Lancet. 2002;359(9309):881–4. https://doi.org/10.1016/S0140-6736(02)07948-5.CrossRefPubMed

36.

Mayhew AJ, Amog K, Phillips S, Parise G, McNicholas PD, de Souza RJ, et al. The prevalence of sarcopenia in community-dwelling older adults, an exploration of differences between studies and within definitions: a systematic review and meta-analyses. Age Ageing. 2019;48(1):48–56. https://doi.org/10.1093/ageing/afy106.

37.

Moon SJ, Kim TH, Yoon SY, Chung JH, Hwang HJ. Relationship between stage of chronic kidney disease and sarcopenia in Korean aged 40 years and older using the Korea National Health and nutrition examination surveys (KNHANES IV-2, 3, and V-1, 2), 2008-2011. PLoS One. 2015;10(6):e0130740. https://doi.org/10.1371/journal.pone.0130740.CrossRefPubMedPubMedCentral

38.

Sui SX, Holloway-Kew KL, Hyde NK, Williams LJ, Tembo MC, Mohebbi M, et al. Handgrip strength and muscle quality in Australian women: cross-sectional data from the Geelong osteoporosis study. J Cachexia Sarcopenia Muscle. 2020;11(3):690–7. https://doi.org/10.1002/jcsm.12544.

39.

Kant AK, Graubard BI. Within-person comparison of eating behaviors, time of eating, and dietary intake on days with and without breakfast: NHANES 2005-2010. Am J Clin Nutr. 2015;102(3):661–70. https://doi.org/10.3945/ajcn.115.110262.CrossRefPubMedPubMedCentral

40.

Watanabe D, Yoshida T, Nanri H, Watanabe Y, Date H, Itoi A, et al. Association between the prevalence of frailty and doubly labeled water-calibrated energy intake among community-dwelling older adults. J Gerontol A Biol Sci Med Sci. 2020. https://doi.org/10.1093/gerona/glaa133.

41.

Dennison EM, Sayer AA, Cooper C. Epidemiology of sarcopenia and insight into possible therapeutic targets. Nat Rev Rheumatol. 2017;13(6):340–7. https://doi.org/10.1038/nrrheum.2017.60.CrossRefPubMed

42.

Baker JF, Long J, Leonard MB, Harris T, Delmonico MJ, Santanasto A, et al. Estimation of skeletal muscle mass relative to adiposity improves prediction of physical performance and incident disability. J Gerontol A Biol Sci Med Sci. 2018;73(7):946–52. https://doi.org/10.1093/gerona/glx064.

43.

Tang TC, Hwang AC, Liu LK, Lee WJ, Chen LY, Wu YH, et al. FNIH-defined sarcopenia predicts adverse outcomes among community-dwelling older people in Taiwan: results from I-Lan longitudinal aging study. J Gerontol A Biol Sci Med Sci. 2018;73(6):828–34. https://doi.org/10.1093/gerona/glx148.

44.

Sun S, Lee H, Yim HW, Won HS, Ko YH. The impact of sarcopenia on health-related quality of life in elderly people: Korean National Health and nutrition examination survey. Korean J Intern Med. 2019;34(4):877–84. https://doi.org/10.3904/kjim.2017.182.CrossRefPubMed

45.

Newman AB, Kritchevsky SB, Guralnik JM, Cummings SR, Salive M, Kuchel GA, et al. Accelerating the search for interventions aimed at expanding the health span in humans: the role of epidemiology. J Gerontol A Biol Sci Med Sci. 2020;75(1):77–86. https://doi.org/10.1093/gerona/glz230.

46.

Dumurgier J, Elbaz A, Ducimetiere P, Tavernier B, Alperovitch A, Tzourio C. Slow walking speed and cardiovascular death in well functioning older adults: prospective cohort study. BMJ. 2009;339(nov10 2):b4460. https://doi.org/10.1136/bmj.b4460.CrossRefPubMedPubMedCentral

47.

Newman AB, Kupelian V, Visser M, Simonsick EM, Goodpaster BH, Kritchevsky SB, et al. Strength, but not muscle mass, is associated with mortality in the health, aging and body composition study cohort. J Gerontol A Biol Sci Med Sci. 2006;61(1):72–7. https://doi.org/10.1093/gerona/61.1.72.

48.

Volpato S, Bianchi L, Cherubini A, Landi F, Maggio M, Savino E, et al. Prevalence and clinical correlates of sarcopenia in community-dwelling older people: application of the EWGSOP definition and diagnostic algorithm. J Gerontol A Biol Sci Med Sci. 2014;69(4):438–46. https://doi.org/10.1093/gerona/glt149.

49.

Fried LP, Rowe JW. Health in aging - past, present, and future. N Engl J Med. 2020;383(14):1293–6. https://doi.org/10.1056/NEJMp2016814.CrossRefPubMed

50.

Ikeda N, Nishi N, Miyachi M. Effects of behavioral counseling on cardiometabolic biomarkers: a longitudinal analysis of the Japanese national database. Prev Med. 2018;113:116–21. https://doi.org/10.1016/j.ypmed.2018.05.016.CrossRefPubMed

Title: Factors associated with sarcopenia screened by finger-circle test among middle-aged and older adults: a population-based multisite cross-sectional survey in Japan
Authors: Daiki Watanabe
Tsukasa Yoshida
Takashi Nakagata
Naomi Sawada
Yosuke Yamada
Kayo Kurotani
Kenji Tanaka
Megumi Okabayashi
Hidekazu Shimada
Hidemi Takimoto
Nobuo Nishi
Keiichi Abe
Motohiko Miyachi
Publication date: 01-12-2021
Publisher: BioMed Central
Keyword: Sarcopenia
Published in: BMC Public Health / Issue 1/2021
Electronic ISSN: 1471-2458
DOI: https://doi.org/10.1186/s12889-021-10844-3

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Factors associated with sarcopenia screened by finger-circle test among middle-aged and older adults: a population-based multisite cross-sectional survey in Japan

Abstract

Background

Methods

Results

Conclusions

Trial registration

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusions

Trial registration

Please log in to get access to this content

Other articles of this Issue 1/2021

Rapid review of COVID-19 epidemic estimation studies for Iran

Comparisons of disease cluster patterns, prevalence and health factors in the USA, Canada, England and Ireland

The use of inappropriate anal douching tool associates with increased HIV infection among men who have sex with men: a cross-sectional study in Shenyang, China

The HIV epidemic in Colombia: spatial and temporal trends analysis

Difficulties detaching psychologically from work among German teachers: prevalence, risk factors and health outcomes within a cross-sectional and national representative employee survey

Poor linkage to care for HIV-positive OVC with disabled caregivers: a longitudinal study in Tanzania